Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
12/2010
12/22/2010CN101921210A Amphiphilic tree-like calixarene used as solubilizer or dispersing agent
12/22/2010CN101920019A Hydrophilic polymer-puerarin specific conjugated non-hemolytic conjugate
12/22/2010CN101920018A Pharmaceutic adjuvant and preparation method thereof
12/22/2010CN101920017A Composite for promoting glycyrrhetinic acid to realize percutaneous permeation
12/22/2010CN101920016A Implants for administering substances and methods of producing implants
12/22/2010CN101919987A Soft capsule for treating vagina
12/22/2010CN101919960A Inflammation and heat clearing tablets and preparation method thereof
12/22/2010CN101919941A External traditional Chinese medicine composition used for renal function curing and health care and application thereof in preparing traditional Chinese medicine cataplasma for renal function curing and health care
12/22/2010CN101919910A Method for preparing traditional Chinese medicine sustained release tablets for treating livestock dysentery and enteritidis
12/22/2010CN101919907A Radix salviae miltiorrhizae extract nano particle and preparation method thereof
12/22/2010CN101919879A Method for preparing probiotics preparation by taking attapulgite as carrier
12/22/2010CN101919869A Forsythoside A drug composite
12/22/2010CN101919866A Drug composition of complex fat-soluble vitamins and preparation method thereof
12/22/2010CN101919865A Capsule type budesonide dry powder inhalation and preparation process thereof
12/22/2010CN101919864A Tolvaptan medicinal composition and preparation method thereof
12/22/2010CN101919863A Cefbuperazone composition
12/22/2010CN101919831A Pharmaceutical composition compounded with compound liposoluble vitamins and preparation method thereof
12/22/2010CN101919829A Hydrogel cataplasm for microneedle cutaneous penetration and preparation method thereof
12/22/2010CN101919828A Transdermal absorption adhesive patch for curing onychomycosis and preparation method thereof
12/22/2010CN101919827A Polysaccharide capsules and methods of preparation
12/22/2010CN101919826A Soft capsule preparation for treating anus and prostate
12/22/2010CN101919825A Solid effervescent mixture for the oral absorption
12/22/2010CN101919824A High-release erythrocin enteric-coated tablet and preparation method thereof
12/22/2010CN101919822A Tablet with improved combination properties and preparation method thereof
12/22/2010CN101919819A Anti-cancer drug preparation taking Solutol HS 15 as solubilizer
12/22/2010CN101919818A Method for preparing tetrandrine lung-targeted controlled-release microspheres
12/22/2010CN101919817A Lafutidine gastric-retention controlled-release composite
12/22/2010CN101919815A Flexible cis-platinum vesicle and preparation method thereof
12/22/2010CN101919813A Method for preparing chitosan nanoparticles with recombinant human endostar for injection
12/22/2010CN101919812A Novel formulation of piperazine ferulate and preparation method thereof
12/22/2010CN101919811A Levetiracetam injection and preparation method thereof
12/22/2010CN101919810A Dexpanthenol infusion preparation and preparation method thereof
12/22/2010CN101919809A New dexpanthenol injection preparation and preparation method thereof
12/22/2010CN101919807A Suppository composition
12/22/2010CN101919806A Freeze-dried agent compound
12/22/2010CN101919805A Freeze-dried form body containing magnesium ascorbyl phosphate
12/22/2010CN101919804A Application of solid dispersion to preparation of veterinary drugs
12/22/2010CN101919803A Controlled release preparation
12/22/2010CN101919802A Solid effervescent mixture for the oral absorption
12/22/2010CN101919801A Solid effervescent mixture for oral absorption
12/22/2010CN101919800A Orodispersible pharmaceutical composition for oral, oromucosal or sublingual administration of agomelatine
12/22/2010CN101919799A Novel sustained-release transdermal medicament delivery system
12/22/2010CN101627972B Entecavir orally disintegrating tablet and method for preparing same
12/22/2010CN101485636B Risperidone orally disintegrating tablets and preparation method thereof
12/22/2010CN101475575B Extraction of tetraodontoxin, and preparation thereof used in drug dependence of dolantin
12/22/2010CN101474411B Anti-tumor prodrug using novel amphipathic hyperbranched polyesters as carrier and preparation method
12/22/2010CN101455641B Anti-cancer medicine liposome preparation sensitive to ray
12/22/2010CN101433588B Method for producing five-ester dropping pills
12/22/2010CN101428035B Gemcitabine hydrochloride or gemcitabine composition
12/22/2010CN101416941B Medical composition loaded with nimustine and synergist thereof
12/22/2010CN101401801B Curcumin glutin microsphere and preparation thereof
12/22/2010CN101392034B Dextran-phosphatidyl ethanolamine polymer micelle and preparation method thereof
12/22/2010CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof
12/22/2010CN101366722B Hydrotalcite doxifluridine slow release formulation and preparation method thereof
12/22/2010CN101297972B Special glue for producing algal polysaccharides plant capsules
12/22/2010CN101264051B Modified release pharmaceutical formulation
12/22/2010CN101239037B Acetylcysteine injection and preparation thereof
12/22/2010CN101185645B Cromoglyn sodium gel eyedrop and preparation method
12/22/2010CN101129375B Vinorelbine solid lipid nano granule, freeze drying formulated product and method of preparing the same
12/22/2010CN101125130B Indian chrysanthemum effervescent preparation and preparation method thereof
12/22/2010CN101120911B Ftibamzone chrisma with propanediol as co-solvent
12/22/2010CN101081219B Composition containing taxane genus compound, the method for preparing the same and the use thereof
12/21/2010US7855197 Administering Diamino-substituted phenothiazinium compound; antimicrobial photosensitisers effective against Gram negative bacteria, Gram positive bacteria; photodynamic therapy
12/21/2010US7855066 the ions include zinc and cobalt which improve Apo-2 ligand trimer formation and stability; tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)
12/21/2010US7854948 Use of tropical root crops in dietary intervention strategies
12/21/2010US7854945 graphitic nanotubes substituted with chemical moieties or upon which certain cyclic compounds are adsorbed; complex structures comprised of such functionalized fibrils linked to one another; introducing functional groups onto the surface of such fibrils
12/21/2010US7854943 Phospholipid gel compositions for drug delivery and methods of treating conditions using same
12/21/2010US7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease
12/21/2010US7854935 Herbal therapy for the treatment of asthma
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010US7854922 Skin preparation for external use characterized by containing sugar derivative of α, α-trehalose
12/21/2010US7854919 Multivalent constructs for therapeutic and diagnostic applications
12/21/2010US7854753 to cellular surfaces without damage; transdermal, transmembrane; with solvent, gelling agent, and photocatalyst has a band gap energy of 2.9 eV to 3.2 e
12/21/2010CA2602926C Non-protein stabilized clostridial toxin pharmaceutical compositions
12/21/2010CA2477885C Pressurised metered dose inhalers containing solutions of beta-2 agonists
12/21/2010CA2468374C Glp-1 derivatives
12/21/2010CA2453823C Dermal therapy using phosphate derivatives of electron transfer agents
12/21/2010CA2448425C Inhalation capsules
12/21/2010CA2441386C Metal substituted non centrosymmetrical phthalocyanine analogues, their preparation and use in photodynamic therapy and in vivo diagnostic
12/21/2010CA2433037C Sustained-release preparation
12/21/2010CA2309326C Pharmaceutical compositions containing cyclodextrins and taxoids
12/19/2010CA2669717A1 Formula and method for treating water in fish tanks
12/16/2010WO2010144869A2 Protease inhibitors
12/16/2010WO2010144785A2 Diketopiperazine microparticles with defined isomer contents
12/16/2010WO2010144755A2 Compositions and methods for delivery of materials
12/16/2010WO2010144629A1 Hemoglobin compositions
12/16/2010WO2010143942A1 Targeted nano-photomedicines for photodynamic therapy of cancer
12/16/2010WO2010143827A2 Oil-gel soft patch for attachment to the skin and method for preparing same
12/16/2010WO2010143711A1 Wound-covering material
12/16/2010WO2010143708A1 Targeting agent for neovascularization
12/16/2010WO2010143689A1 Microneedle device
12/16/2010WO2010143218A1 Polymeric conjugates of phospholipids
12/16/2010WO2010143193A1 Targeted liposomes comprising n-containing bisphosphonates and uses thereof
12/16/2010WO2010142850A1 Hydrophobins for dispersing active agents
12/16/2010WO2010142665A1 Glp-1 and fgf21 combinations for treatment of diabetes type 2
12/16/2010WO2010142457A1 Semi-solid compositions and pharmaceutical products
12/16/2010WO2010142456A1 Solid compositions comprising 5-aminolevulinic acid
12/16/2010WO2010142035A1 Fusion proteins for delivery of gdnf and bdnf to the central nervous system
12/16/2010WO2010122574A3 Coated capsule
12/16/2010WO2010094698A3 Switchable affinity binders
1 ... 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 ... 1712